www.fuentesandres.es
Line devise corrective measures for pipeline projects by understanding lysosomal storage disorder pipeline depth and focus of lysosomal storage disorder therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline roduct description 45 mechanism of action 45 r&d progress 45 metazym - drug profile 46 product description 46 mechanism of action 46 r&d progress 46 drug for mucopolysaccharidosis i,ii,iiia,iiib,iiic - drug profile 47 product description 47 mechanism of action 47 r&d progress 47 busulfan + cyclophosphamide + antithymocyte globulin + allogeneic stem cell transplantation - drug profile 48 product description 48 mechanism of action 48 r&d progress 48 campath + clofarabine + melphalan + hematopoietic stem cell transplantation + radiation therapy - drug profile 49 product description 49 mechanism of action 49 r&d progress 50 busulfan + cyclophosphamide + antithymocyte globulin + hematopoietic stem cell transplantation - drug profile 51 product description 51 mechanism of action 51 r&d progress 51 busulfan + cyclophosphamide + antithymocyte globulin + hematopoietic stem cell transplantation - drug profile 53 product description 53 mechanism of action 53 r&d progress 53 hgt 2310 - drug profile 55 product description 55 mechanism of action 55 r&d progress 55 jr-101 - drug profile 56 product description 56 mechanism of action 56 r&d progress 56 laronidase ert + hematopoietic stem cell transplantion - drug profile 57 product description 57 mechanism of action 57 r&d progress 57 hurler's program - drug profile 59 product description 59 mechanism of action 59 r&d progress 59 gc1111 - drug profile 60 product description 60 mechanism of action 60 r&d progress 60 sbc-106 - drug profile 61 product description 61 mechanism of action 61 r&d progress 61 sbc-103 - drug profile 62 product description 62 mechanism of action 62 r&d progress 62 ald-601 - drug profile 63 product description 63 mechanism of action 63 r&d progress 63 np003 - drug profile 64 product description 64 mechanism of action 64 r&d progress 64 amigal + enzyme replacement therapy - drug profile 65 product description 65 mechanism of action 65 r&d progress 65 isu303 - drug profile 67 product description 67 mechanism of action 67 r&d progress 67 lysosomal storage disorder therapeutics – drug profile updates 68 lysosomal storage disorder therapeutics - discontinued products 72 lysosomal storage disorder - featured news 73 feb 16, 2011: amicus therapeutics provides positive data update from phase ii long. ed problems daily viagra message boards viagra no prescription ed problems daily viagra message boards viagra vgr 100 order viagra online generic viagra viagra coupon viagra generic daily viagra vs. 36 hour viagra ed problems daily viagra message boards viagra uk net reviews over the counter herbal viagra cheap viagra Dirección: Av/ Libertad 13, Entresuelo Dcha, CP: 03690
San Vicente del Raspeig (Alicante)
 
Teléfono: 965 66 08 54 / Fax: 965 66 18 85
E-Mail: E-Mail